Kestra Medical Technologies, Ltd. (KMTS) stock forecast and price target
Price $28.64 · data as of November 13, 2026
12-month price target
Average target$31.12
Upside / downside+8.7%
Analysts8
ConsensusStrong buy
Low $28.00Average $31.12High $34.00
Gold marker: average target · white marker: today’s price ($28.64)
Analyst ratings
Strong buy 2Buy 6Hold 1Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends April 30, 2027 | $-2.45 | −43.4% | $141M |
| Next fiscal year ends April 30, 2028 | $-2.06 | +16.1% | $196M |
| Quarter after ends January 31, 2027 | $-0.57 | −42.3% | $35M |
Consensus of the analysts covering Kestra Medical Technologies, updated daily. In the last 30 days 0 estimates were raised and 2 lowered.
Frequently asked questions
What is the Kestra Medical Technologies stock price target?
The average 12-month target from 8 analysts is $31.12, 8.7% above the current price of $28.64 Targets range from $28.00 to $34.00.
Is Kestra Medical Technologies a buy according to analysts?
The consensus rating is “Strong buy” (2 strong buy, 6 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is Kestra Medical Technologies expected to earn?
Analysts expect EPS of $-2.45 for the fiscal year ending April 30, 2027 and $-2.06 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.